Today: 20 May 2026
Experian PLC stock ticks up after buyback trade; May results loom for EXPN
26 February 2026
1 min read

Experian PLC stock ticks up after buyback trade; May results loom for EXPN

London, February 26, 2026, 09:16 (GMT) — Regular session

Experian PLC (EXPN.L) advanced roughly 1% Thursday, after the credit data firm announced fresh share buybacks aimed at reducing its outstanding shares. By 0916 GMT, the stock traded 27 pence higher at 2,688 pence.

The buyback news is notable for Experian, which has been working to regain its footing after a challenging period. The consistent daily repurchases have been lending some stability to the stock. On Wednesday, shares jumped 3.94%. Still, MarketWatch data indicate the stock is trading roughly 35% off its 52-week peak of £41.01, set on July 18.

Experian kicked off its buyback on January 30, laying out a ceiling of $1 billion and planning to wrap up by June 30, 2027. The tempo depends on how markets and internal demands play out. According to the company, the buyback aims both to shrink the number of shares outstanding and to cover roughly $200 million owed on employee share plans.

Experian, in a Thursday RNS, disclosed it picked up 399,433 shares on February 25 via J.P. Morgan Securities at a weighted average price of 2,622.1614 pence. The company plans to cancel those shares.

Shares shifted as UK blue chips hovered just off record territory, though dipped a bit at the open. By 0813 GMT, the FTSE 100 slipped 0.08% while investors sifted through a slate of corporate earnings.

Outside the capital returns update, Experian on Tuesday pointed to new research it had commissioned from Forrester Consulting. The survey found 64% of EMEA and Asia Pacific businesses saw higher fraud losses in the past year. “Generative AI is giving criminals unprecedented speed and sophistication,” said Shail Deep, chief operating officer for Experian EMEA & APAC. experianplc.com

Buybacks shrink the pool of shares on the market, often pushing up earnings per share—assuming profits don’t budge. Investors can spot these moves easily; the transactions land routinely in market filings.

But these aren’t foolproof. A slowdown in lending, or tougher restrictions on data use, can quickly sap growth. That puts the buyback narrative at risk, and the share price could slide right along with the cycle.

Investors are eyeing if the stock manages to hang on to its recent gains as the company continues its buybacks. Another focus: how credit conditions shape up heading into spring—whether the broader implications improve or deteriorate from here.

Next up: Experian posts its preliminary full-year results on May 20.

Stock Market Today

  • Williams-Sonoma Gains 1.58% as Market Declines, Eyes Upcoming Earnings
    May 19, 2026, 7:31 PM EDT. Williams-Sonoma (WSM) shares rose 1.58% to $171.83, outperforming the S&P 500's 0.67% drop. The stock had declined 16.27% over the past month, lagging the sector's 0.69% loss but behind the S&P 500's 4% gain. Investors await WSM's upcoming earnings report, expected to show $1.80 per share in EPS, down 2.7% year-over-year, with revenue projected to rise 4.25% to $1.8 billion. The company's full-year estimates anticipate 4.75% EPS growth and 4.39% revenue growth. Analyst estimate revisions have nudged EPS projections higher by 0.58% in 30 days, with WSM holding a Zacks Rank #3 (Hold). Valuation indicators show a Forward P/E of 18.27, slightly below industry average, while the PEG ratio of 2.12 exceeds the Retail - Home Furnishings sector average of 1.63.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
Netflix stock jumps 6% on Warner bid twist — what investors watch next
Previous Story

Netflix stock jumps 6% on Warner bid twist — what investors watch next

Intuit stock price jumps on Anthropic AI deal as earnings loom — what investors watch Thursday
Next Story

Intuit stock price jumps on Anthropic AI deal as earnings loom — what investors watch Thursday

Go toTop